Sitemap
September 10, 2020 Articles
Filter by Available Specialty
- ACG develops clinical guidelines for diagnosis, treatment of achalasia
- Aldeyra to undertake phase 2 trial of ADX-629 in patients hospitalized with COVID-19
- Allergic contact dermatitis to liquid adhesive, mesh system seen after orthopedic surgery
- App helps reduce eating disorder symptoms in college-aged women
- Baxter’s dialyzer, recently granted marketing authorization, may improve hemodialysis
- Black individuals at higher risk for ADHD vs. general population
- Canakinumab may reduce total knee, hip replacement, OA symptoms
- Cardiac outpatients commonly have psychiatric disorders
- Commonly prescribed medication shows no link to recurrent AKI, may decrease mortality risk
- Comorbidities, not age, linked with worse safety outcomes for Entyvio, Stelara
- COVID-19 adds urgency to fight against inequities in cancer care
- COVID-19 pandemic could reverse efforts to prevent child deaths globally
- Daratumumab regimen benefits Black patients with newly diagnosed multiple myeloma
- David B. Duong, MD, MPH
- Digital cognitive behavioral therapy reduces insomnia severity, improves quality of life
- Electronic alert may reduce excessive prescribing of short-acting asthma relievers
- FDA approves Trelegy Ellipta for new asthma indication
- FDA clears device for postpartum bleeding
- Fludarabine-busulfan regimen confers favorable long-term outcomes in myelofibrosis
- 'Future therapies' in clinical trials may revise ability to treat systemic sclerosis
- GCA, TAK likely react differently to tocilizumab, despite disease similarities
- IDSA issues new guidance for antimicrobial-resistant infections
- Influenza season could create ‘perfect storm’ for COVID-19 outbreaks
- Intensive BP-lowering treatment does not raise risk for orthostatic hypotension
- Ixazomib regimen fails to extend PFS in transplant-ineligible multiple myeloma
- Lessons from collaboration between adult and pediatric endocrinologists
- Lilly extends $35 insulin copay card introduced during COVID-19
- Metformin increases risk for moderate anemia in type 2 diabetes
- Mixed beliefs, practices affect hypertension diagnoses
- More than 40% of US adults skipped medical care since COVID-19
- New data further support novel treatment for Cushing’s syndrome
- Newer migraine therapies may yield fewer side effects
- OLYMPIA: TearCare treatment improves dry eye signs, symptoms
- Patients with Medicaid have low functional outcome scores after shoulder arthroplasty
- Phase 2 trial of RGX-314 to treat wet AMD underway
- Precision medicine for lung cancer a ‘rapidly evolving field’
- Precision medicine uses multiomic details to battle kidney disease
- Provider evaluates methoxy polyethylene glycol-epoetin beta in peritoneal dialysis
- Researchers use antibiograms to monitor statewide changes in drug resistance
- Separation anxiety
- Studies find hypertension most prevalent comorbidity in patients hospitalized for COVID-19
- Top in hem/onc: Blood test for cancer, glioblastoma treatment
- Topical roflumilast to move to phase 3 trials for atopic dermatitis
- Venetoclax regimen extends OS in AML subset
- VOYAGER PAD: Treatment effect of rivaroxaban in PAD strongest in concomitant CAD